A Kansas woman has joined the growing litigation involving proton pump inhibitors, after allegedly developing kidney failure due to her use of Prilosec. Her recent lawsuit claims that AstraZeneca failed to adequately warn the public about the kidney risks associated with the popular heartburn medication.
According to the August 31st filing in the U.S. District Court, District of Kansas, Jackie Koon used Prilosec from 2010 up through 2013 to treat (GERD), peptic ulcer disease, and gastropathy caused by nonsteroidal anti-inflammatory drugs. She claims that her use of the medication eventually resulted in End Stage Renal Disease (kidney failure), causing severe and permanent personal injuries, pain, suffering, and emotional distress.
The complaint asserts that AstraZeneca has received numerous reports of Prilosec-induced kidney injuries, yet failed to include appropriate safety warnings or information on the medication’s label.
“Specifically, Defendants had received numerous case reports of kidney injuries in patients that had ingested Prilosec by as early as 1989,” the lawsuit states. “These reports of numerous kidney injuries put Defendants on notice as to the excessive risks of kidney injuries related to the use of Prilosec. However, Defendants took no action to inform Plaintiff or Plaintiff’s physicians of this known risk. Instead, Defendants continued to represent that Prilosec did not pose any risk of kidney injuries.”
Kidney injury lawsuits involving Prilosec and other proton pump inhibitors have been mounting in U.S. courts in recent months, following the publication of several studies that suggested the medications might be associated with an increased risk of acute kidney injury, chronic kidney disease and renal failure. The drugs, which include both prescription and over-the-counter versions of Prilosec, Nexium, Prevacid and others, were used by some 15 million Americans in 2013, leading some legal experts to anticipate a large litigation
Earlier this month, the nationwide law firm of Bernstein Liebhard LLP announced that it had filed a Nexium lawsuit on behalf of an Illinois man who allegedly developed chronic kidney disease related to the use of that medication. In an interview with Bloomberg Law, partner Daniel Burke revealed that the Firm had received hundreds of similar inquires from proton pump inhibitor users, and is now in the process investigating medical records for a number of potential clients. Mr. Burke speculated that the proton pump inhibitor litigation could eventually become large enough to warrant the creation of a multidistrict litigation or other centralized court proceeding.
Bernstein Liebhard LLP continues to offer free case evaluations to individuals who experienced kidney complications that may be linked to proton pump inhibitors, including Nexium, Prilosec and Prevacid. To learn more, please call (888) 994-8177.